Literature DB >> 26239729

Gain-of-function single nucleotide variants of the CYP2C19 gene (CYP2C19*17) can identify subtherapeutic voriconazole concentrations in critically ill patients: a case series.

Joachim D Weigel1, Nicole G M Hunfeld2,3, Birgit C P Koch3, Mohamud Egal2, Jan Bakker2, Ron H N van Schaik4, Teun van Gelder3,5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26239729     DOI： 10.1007/s00134-015-4002-z

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  5 in total

1.  Effect of cytochrome P450 2C19 genotype on voriconazole exposure in cystic fibrosis lung transplant patients.

Authors:  Maud Berge; Romain Guillemain; David A Trégouet; Catherine Amrein; Veronique Boussaud; Patrick Chevalier; Agnes Lillo-Lelouet; Christine Le Beller; Pierre Laurent-Puig; Philippe H Beaune; Eliane M Billaud; Marie-Anne Loriot
Journal:  Eur J Clin Pharmacol       Date:  2010-10-31       Impact factor: 2.953

Review 2.  Aspergillosis.

Authors:  Brahm H Segal
Journal:  N Engl J Med       Date:  2009-04-30       Impact factor: 91.245

3.  A prospective randomized evaluation of a pharmacogenomic approach to antiplatelet therapy among patients with ST-elevation myocardial infarction: the RAPID STEMI study.

Authors:  D Y F So; G A Wells; R McPherson; M Labinaz; M R Le May; C Glover; A J Dick; M Froeschl; J-F Marquis; M H Gollob; L Tran; J Bernick; B Hibbert; J D Roberts
Journal:  Pharmacogenomics J       Date:  2015-04-07       Impact factor: 3.550

4.  Multicenter study of voriconazole pharmacokinetics and therapeutic drug monitoring.

Authors:  Michael J Dolton; John E Ray; Sharon C-A Chen; Kingsley Ng; Lisa G Pont; Andrew J McLachlan
Journal:  Antimicrob Agents Chemother       Date:  2012-07-02       Impact factor: 5.191

Review 5.  Therapeutic drug monitoring of voriconazole.

Authors:  Roger J M Brüggemann; J Peter Donnelly; Rob E Aarnoutse; Adilia Warris; Nicole M A Blijlevens; Johan W Mouton; Paul E Verweij; David M Burger
Journal:  Ther Drug Monit       Date:  2008-08       Impact factor: 3.681
  5 in total
  3 in total

1.  PharmGKB summary: voriconazole pathway, pharmacokinetics.

Authors:  Julia M Barbarino; Aniwaa Owusu Obeng; Teri E Klein; Russ B Altman
Journal:  Pharmacogenet Genomics       Date:  2017-05       Impact factor: 2.089

2.  Applying Pharmacogenomics to Antifungal Selection and Dosing: Are We There Yet?

Authors:  Matthew A Miller; Yee Ming Lee
Journal:  Curr Fungal Infect Rep       Date:  2020-01-16

3.  Correlation of CYP2C19 genotype with plasma voriconazole exposure in South-western Chinese Han patients with invasive fungal infections.

Authors:  Qiang Miao; Jiang-Tao Tang; Teun van Gelder; Ya-Mei Li; Yang-Juan Bai; Yuan-Gao Zou; Lan-Lan Wang; Yun-Ying Shi
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.817
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.